Use of amantadine

PDMED_AMANTADINE

No definition available.

Endpoint definition

FinnGen phenotype data

321302 individuals

diagram downward connector

Apply sex-specific rule None

321302

diagram downward connector

Check conditions None

321302

diagram downward connector
diagram bullet

Filter registries

Medicine purchases: ATC N04BB01

1534

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

330

diagram downward connector
diagram bullet

Check minimum number of events

Min. number of events 3

330

diagram downward connector

Include endpoints None

330

diagram downward connector
PDMED_AMANTADINE

Extra metadata

First used in FinnGen datafreeze DF2

Summary Statistics

Key figures

All Female Male
?
Number of individuals
324 225 99
?
Unadjusted prevalence (%)
0.11 0.13 0.07
?
Mean age at first event (years)
52.84 50.01 59.27

?
Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: PDMED_AMANTADINE – Use of amantadine
GWS hits:

Survival analyses between endpoints

Plot

before Use of amantadine
after Use of amantadine

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Use of amantadine